--- the subscriber area has no ads and those above are not selected or endorsed by this site ---


EMAN short squeeze, MACom products and MX OMIBs +3


Shares of eMagin have spiked over 35% after hours to about $1.50, after declining recently.  I see this a a belated short capitulation after the defense contract announcement basically confirmed that eMagin will have a sustainable, if not profitable, business for at least the next 3 years, barring a change in defense budgeting.  As of mid-July, shorted float had been fairly steady at 2.1M shares, which is under 4%, but the rebate rate, which had been chopping downward through the thirties, is now at 25%.  It's notoriously difficult to predict the tops of squeezes, but with very little daily trading volume, this could go much higher.  The pre-election gamble is paying off!

MACom is also looking to benefit from defense spending with a new line of best-in-class millimeter wave switches.  This isn't nearly enough to get me interested in MTSI at current prices, but the capabilities and small footprint do represent a significant positive.  These factors also lead me to wonder about usage of Resonant's filters and I am making inquiries. 

Finally, MagnaChip has just reported two open market insider buys from the CEO and a Director.  I have no interest in the stock in the high $11 range where purchases were made, but I've already conceded the possibility of M&A and, in very different ways, the results from both Fitbit and MicroVision are further evidence that just about anything can happen in the current economic environment.